The scenario on HIV, Tuberculosis and Malaria (HTM) in Africa indicates that among the three diseases, HIV has the lowest gap to attain the Sustainable Development Goal 2030 target. However, although there has been very strong progress in reducing AIDS-related deaths in countries supported by the Global Fund, progress is mixed, varying significantly between regions.…
Details
The Global Fund has an inclusive governance system. However, it is it equitable? Can we save more lives with a better representation of Africa which, after all, receives more than 70% of Global Fund monies? The African Constituencies are requesting at least one additional voting seat on the Global Fund Board. The Board currently comprises…
Details
According to the World Health Organisation (WHO), Cameroon, located in Central Africa, is ranked among the 30 High Tuberculosis (TB) burden countries in the world. The 2022 Global Fund Report Findings on Cameroon 25,000 people are undergoing TB treatment; 150 people are on Multidrug-resistant TB treatment (MDR-TB); 4,200 people with HIV and TB are on…
Details
Over the past few decades, Global Health Initiatives (GHIs) have made significant contributions to remarkable advancements in safeguarding lives and enhancing the overall well-being of people worldwide. Their achievements include substantial progress in combating specific diseases such as polio, malaria, tuberculosis, and HIV/AIDS, as well as expanding the reach of targeted healthcare interventions like vaccination…
Details
The Global Fund Implementer Constituencies Group (IMG)organised a retreat in Montenegro for Board Members (BMs) and Alternate Board Members (ABMs) from October 5-7, 2023. The main objectives of the retreat were to define the Implementer Constituencies Group (hereinafter referred to as IMG in the short-form) in terms of its mode of work, role and representative…
Details
Background Due to the dedication of the national leadership, half of the HTM funding has been provided by the government since 2021, with the other half coming from cooperating partners. The Ministry of Health and Social Services is the Principal Recipient (PR) of resources from the Global Fund. Despite the incredible progress, the Office of…
Details
Since 2005, the Global Fund has awarded over $557 million (€557.3 million) of grants and disbursed more than $425 million (€425.2 million) to Chad. Active grants total $149.6 million (€149.7 million) for the 2020-2022 funding allocation period (June 2021 to December 2024 implementation period). It is worth noting that the Global Fund operates in a…
Details
The African Constituency Bureau (ACB), in a strategic alliance with the Global Fund, WHO AFRO, FGHI, and GAVI, convened a side event at the 73rd WHO/AFRO Regional Committee. Titled “Strategic Priorities for Africa’s Engagement in Global Health Initiatives,” the event was a watershed moment, signaling Africa’s ascendant role in shaping the future of global health.…
Details
As the ACB commemorated its 5th anniversary in 2022, the spirit of passion and determination remained unwavering. In 2023, a new chapter unfolds, marked by a significant move to the Africa CDC compound. This relocation is not just about geography; it signifies closer proximity to the heart of African health efforts, enabling the ACB to better serve the continent. Gratitude is extended to the ACB Board Chair, Dr. Jean Jacques Mbungani, the ACB Board members, Mr. Josephat Kakoma, the Executive Director, and H. E. Dr. Jean Kaseya Director General of the Africa CDC, whose partnership has made this move possible.
Details
The Office of the Inspector General (OIG) released three audit findings for Global Fund (GF)- supported programs in Uganda, South Africa, and Zimbabwe pointing out malfeasant conduct among recipients of GF resources in these countries; in violation of the GF’s Operational Framework for all the programs that receive GF support. At the time of publication of this summary, except for Zimbabwe, the Country Coordinating Mechanisms (CCMs) for Uganda and South Africa had shared their reflections on the OIG findings.
Details